Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia

NCT02649504 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia

Interventions

DRUG: Rituximab
DRUG: Dexamethasone
DRUG: Mycophenolate mofetil
DRUG: Placebo

Sponsor

Weill Medical College of Cornell University